OTCM
MHUAF
Market cap2mUSD
Jul 27, Last price
8.77USD
1D
0.00%
IPO
3.79%
Name
Meihua International Medical Technologies Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Meihua International Medical Technologies Co., Ltd. is a Chinese company dedicated to the innovation, production, and distribution of a wide array of medical devices. Operating primarily within the People's Republic of China, its comprehensive product portfolio spans various regulatory classifications. The company offers numerous Class I disposable medical supplies, such as medical X-ray and dry films, dry laser imagers, gauze bandages, and examination gloves. It also provides pharmaceutical packaging, including low-density polyethylene eye drop bottles and high-density polyethylene tablet bottles. Its Class II inventory comprises critical disposable instruments and kits for medical procedures, including complete anesthesia kits, specialized medical brushes, various examination and urethral catheterization sets, endotracheal intubation devices, medical masks, anal bags, and suction connecting tubes. For Class III disposable medical devices, Meihua manufactures advanced solutions like single-use infusion pumps, sophisticated anesthesia puncture kits, and electronic pump systems. Beyond these, the company also produces disposable plastic baby bottles and components like NB/PSN rubber covers and 8.2mL folded spoons for tools and containers. It specializes in Class II 6866 medical polymer materials and products, such as transfusion equipment, pipelines, and endotracheal intubation for respiratory care, alongside traditional medical X-ray films and multi-functional self-extracting X-ray film machines. Meihua caters to a broad customer base, including hospitals, pharmacies, medical institutions, and medical equipment companies. Its products are distributed globally, reaching markets throughout Europe, North America, South America, Asia, Africa, and Oceania. Founded in 1991, the company is headquartered in Yangzhou, People's Republic of China.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||